Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease

@inproceedings{Kostas2017FecalCM,
  title={Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease},
  author={Athanasios Kostas and Spyros I Siakavellas and Christophoros Kosmidis and Anna Takou and Joanna Nikou and Georgios Maropoulos and John Vlachogiannakos and George V. Papatheodoridis and Ioannis G Papaconstantinou and Giorgos Bamias},
  booktitle={World journal of gastroenterology},
  year={2017}
}
AIM To evaluate the utility of fecal calprotectin (FC) in predicting relapse and endoscopic activity during follow-up in an inflammatory bowel disease (IBD) cohort. METHODS All FC measurements that were obtained during a 3-year period from patients with inflammatory bowel disease in clinical remission were identified. Data regarding the short-term (6 mo) course of the disease were extracted from the medical files. Exclusion criteria were defined as: (1) An established flare of the disease at… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

12 its scope and utility in the management of inflammatory bowel disease

JY Xiang, Q Ouyang, GD Li, NP. Xiao
  • J Gastroenterol
  • 2016